|
The said drug is equivalent to reference listed drug, Lopressor 25 mg, 50 mg and 100 mg. Metoprolol is used with or without other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems.
This medication is also used to treat chest pain (angina) and to improve survival after a heart attack. Metoprolol belongs to a class of drugs known as beta blockers. It works by blocking the action of certain natural chemicals in body, such as epinephrine, on the heart and blood vessels. This effect lowers the heart rate, blood pressure, and strain on the heart.
The drug will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh, (India).
Metoprolol Tartrate tablets USP, 25 mg, 50 mg, and 100 mg had annual sales of $45.2 million in the United States (IQVIA MAT February 2023).
As on 31 December 2022, the group now has 364 approvals and has so far filed over 440 ANDAs since the commencement of the filing process in FY 2003-04.
Zydus Lifesciences is engaged in an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The product portfolio of the company includes active pharmaceutical ingredients [API] and human formulations.
The company's consolidated net profit jumped 24.5% to Rs 622.90 crore on 17.9% rise in net sales to Rs 4,159.80 crore in Q4 FY23 over Q4 FY22.
The scrip declined 1.58% to Rs 509.10 on the BSE.
|